Results 41 to 50 of about 28,778 (289)

Carbapenem-Resistant Gram-Negative Bacilli Causing Ventilator Associated Pneumonia: Study of MASTDISCS Combi Carba Plus for Detection of Carbapenemase Producing Enterobacterales

Infection and Drug Resistance, 2022
Eman E Hegazy,1 Marwa Gamal Bahey,1 Alaa Mohammed Abo Hagar,2 Amira Abdelgalil Elkholy,3 Esraa A Mohamed1 1Department of Medical Microbiology and Immunology, Faculty of Medicine, Tanta University, Tanta, Egypt; 2Department of Anesthesiology, Surgical ...
Hegazy EE, Bahey MG, Abo Hagar AM, Elkholy AA, Mohamed EA   +4 more
doaj  

Risk Factors and Outcomes of Bacteremia Caused by Carbapenem Resistant Enterobacterales Compared to Carbapenem Susceptible Enterobacterales

, 2021
Abstract BackgroundDue to shrinking therapeutic options, infections due to Carbapenem-resistant Enterobacterales (CRE) are an urgent threat in healthcare systems. We compared the risk factors and outcomes of bacteremia secondary to CRE with bacteremia secondary to carbapenem susceptible Enterobacterales (CSE).MethodsWe conducted a retrospective
Fasih Ali Ahmed, Omair Ahmed, Sameer Ahmad Khan, Naveera Khan, Sara Ahmed, Muneeba Ahsan Sayeed, Safia Awan, Faraz Siddiqui, Syed Faisal Mahmood   +8 more
openaire   +1 more source

Consenso de expertos para el tratamiento antimicrobiano de las infecciones causadas por bacilos gram negativos multirresistentes en pacientes adultos

Infectio, 2023
Bacterial resistance is a high-impact phenomenon for global public health. Although surveillance networks have been built and new technologies have been de-veloped for the resistance phenomenon characterization, there are still several challenges to be ...
Carlos Arturo Álvarez-Moreno
doaj   +1 more source

Effective phage cocktail to combat the rising incidence of extensively drug-resistant Klebsiella pneumoniae sequence type 16

Emerging Microbes and Infections, 2022
Bacteriophages are the most abundant organisms on Earth. As there are few effective treatment options against some pathogens, the interest in the bacteriophage control of multi-drug-resistant bacterial pathogens is escalating, especially for Klebsiella ...
Willames M. B. S. Martins, Mei Li, Kirsty Sands, Michael H. Lenzi, Edward Portal, Jordan Mathias, Priscila P. Dantas, Roberta Migliavacca, James R. Hunter, Eduardo A. Medeiros, Ana C. Gales, Mark A. Toleman   +11 more
doaj   +1 more source

Epidemiology and Genetic Traits of Carbapenemase-Producing Enterobacterales: A Global Threat to Human Health

Antibiotics
Carbapenemase-producing Enterobacterales (CPE) represent an important threat to global health, resulting in an urgent issue in clinical settings. CPE often exhibit a multidrug-resistant (MDR) phenotype, thus reducing the antimicrobial armamentarium, with
G. Alvisi, A. Curtoni, Rossella Fonnesu, Aurora Piazza, Caterina Signoretto, Giorgia Piccinini, Davide Sassera, P. Gaibani   +7 more
semanticscholar   +1 more source

Enterobacterales colonisation of hospital sink drains

, 2020
Supplementary data repository for a study of enterobacterales colonisation of hospital sink ...
Bede Constantinides (455146)
core   +1 more source

Global prevalence of cefiderocol non-susceptibility in Enterobacterales, Pseudomonas aeruginosa, Acinetobacter baumannii and Stenotrophomonas maltophilia: a systematic review and meta-analysis.

Clinical Microbiology and Infection, 2023
BACKGROUND Cefiderocol is a last resort option for carbapenem-resistant (CR) Gram-negative bacteria, especially metallo-β-lactamase (MBL)-producing Pseudomonas aeruginosa and CR Acinetobacter baumannii.
Stamatis Karakonstantis, Maria Rousaki, Loukia Vassilopoulou, Evangelos I. Kritsotakis   +3 more
semanticscholar   +1 more source

Cefepime-enmetazobactam: first approved cefepime-β- lactamase inhibitor combination for multi-drug resistant Enterobacterales

Future Microbiology
Cefepime-enmetazobactam is a β-lactam/β-lactamase inhibitor (BL/BLI) combination that has demonstrated potent activity against extended spectrum beta-lactamase (ESBL)-producing Enterobacterales, recently approved by the US FDA for the treatment of ...
T. Bhowmick, Rafael Cantón, F. Pea, J. Quevedo, A. Santerre Henriksen, J. Timsit, K. S. Kaye   +6 more
semanticscholar   +1 more source

Antimicrobial Susceptibility Trends Among Gram-Negative Bacilli Causing Bloodstream Infections: Results from the China Antimicrobial Resistance Surveillance Trial (CARST) Program, 2011–2020

Infection and Drug Resistance, 2022
Mengyao Yan, Bo Zheng, Yun Li, Yuan Lv Institute of Clinical Pharmacology, Peking University First Hospital, Beijing, People’s Republic of ChinaCorrespondence: Yun Li; Yuan Lv, Institute of Clinical Pharmacology, Peking University First Hospital, Xueyuan
Yan M, Zheng B, Li Y, Lv Y
doaj  

Evaluating Cefiderocol in the Treatment of Multidrug-Resistant Gram-Negative Bacilli: A Review of the Emerging Data

Infection and Drug Resistance, 2020
Daniele Roberto Giacobbe,1,2 Eugenio Ciacco,3 Corrado Girmenia,4 Federico Pea,5,6 Gian Maria Rossolini,7,8 Giovanni Sotgiu,9 Carlo Tascini,10 Mario Tumbarello,11,12 Pierluigi Viale,5,6 Matteo Bassetti1,2 On behalf of the ISGRI-SITA (Italian Study Group ...
Giacobbe DR, Ciacco E, Girmenia C, Pea F, Rossolini GM, Sotgiu G, Tascini C, Tumbarello M, Viale P, Bassetti M   +9 more
doaj